Abstract
The MICs and MBCs of ciprofloxacin were determined for clinical isolates of antibiotic-resistant aerobic bacteria. Decreased susceptibility to ciprofloxacin of cefotaxime- and amikacin-resistant Serratia marcescens and amikacin-resistant Pseudomonas aeruginosa strains were noted. The data suggest that ciprofloxacin susceptibility should be carefully monitored in treating patients with hospital-acquired bacterial infections.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amikacin / pharmacology*
-
Cefotaxime / pharmacology*
-
Ciprofloxacin
-
Cross Infection / microbiology
-
Gram-Negative Bacteria / drug effects*
-
Humans
-
Kanamycin / analogs & derivatives*
-
Methicillin / pharmacology*
-
Penicillin Resistance
-
Quinolines / pharmacology*
-
Staphylococcus / drug effects*
Substances
-
Quinolines
-
Kanamycin
-
Ciprofloxacin
-
Amikacin
-
Cefotaxime
-
Methicillin